F-PDO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

F-PDO Trademark

Serial Number: 79244654 • Registration: 6191904

F-PDO is a trademark filed by Public University Corporation Fukushima Medical University on July 17, 2018. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Public University Corporation Fukushima Medical University (6 trademarks)

1 Hikariga-oka
Fukushima 960-1295 , JP

Entity Type: 03

Trademark Details

Filing Date

July 17, 2018

Registration Date

November 10, 2020

Published for Opposition

August 25, 2020

Goods & Services

Proteins and protein arrays for use in scientific and medical research; enzymes for scientific and research purposes; reagents for analysis and detection of proteins, other than for medical or for medical or veterinary diagnostic use; cells for scientific, laboratory, or medical research; medium for cell culture or microbial culture, other than for medical or veterinary diagnostic or medical use, namely, cell culture media for scientific and research use; reagents for gene research, other than for medical or veterinary use; inspection reagents for scientific and research purposes consisting of DNA chips and protein chips, other than for medical or for medical or veterinary diagnostic use; blood separating agent in the nature of silicates; albumin from animals or vegetables for scientific and medical research; nucleic acid products, namely, DNA, RNA, oligonucleotides, nucleosides and reagents to conduct sequencing for scientific research purposes other than for medical or for medical or veterinary diagnostic purposes; antibodies, other than for medical or veterinary use, namely, biochemicals in the nature of monoclonal or polyclonal antibodies for in vitro scientific or research use; biological tissue cultures, other than for medical or veterinary purposes; chemical reagents, namely, kits containing chemical reagents for scientific purposes other than for diagnostic, medical or veterinary purposes; chemicals, namely, chemical preparations for scientific purposes, other than for medical or for medical or veterinary diagnostic use; plant growth regulators, namely, substances for regulating plant growth; plant food; higher fatty acids for use in scientific research; test strips, other than for medical purposes, namely, chemically-treated non-medical test strips for calibration of laboratory test equipment; photographic materials, namely, photographic chemicals; vectors, other than for medical or for medical or veterinary diagnostic purposes, namely, nucleic acid products in the nature of molecules for modifying genetic materials in scientific research; plasmid, other than for medical, medical diagnostic or veterinary diagnostic purposes, namely, nucleic acid products in the nature of molecules for modifying genetic materials in scientific research

Scientific research, testing and analysis services in the field of life science, pharmaceuticals, genetics, cancer detection and treatment; pharmaceutical testing, inspection, research or development services in the fields of proteins, antibodies, microorganisms and cells; pharmaceutical testing, inspection, research or development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology and gene expression system; pharmaceutical testing, inspection, research or development on cell and tissue culture; testing, inspection, research or development of drugs and biologics for the prevention and treatment of diseases in the fields of autoimmunity, inflammation, oncology, fibrosis and nerve cell degeneration; testing, research, inspection or development of cancer vaccine; pharmaceutical testing, inspection, research or development of clinical trials, drugs, and biologics for the medical treatment of cancer; testing, inspection, research or development on genes, regarding genetic mutation and expression profile, and providing information relating thereto, in the field of genetics and genetic engineering; providing information on testing, inspection or research on DNA sequence, RNA sequence or amino acid sequence of protein in the field of life science; analysis or screening of DNA, RNA or protein in the field of life science for scientific research purposes; testing, inspection or research of pharmaceuticals, chemicals, cosmetics, reagents and foods, and providing scientific advice and information on the foregoing; quality evaluation for others in the field of pharmaceuticals and clinical trials; providing quality assurance services in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of medical treatments for cancers and providing consultation and information on the foregoing; testing and research in the field of biotechnology and providing consultation and information on the foregoing; testing and research in the field of genetics, and providing information on the foregoing; research and consultancy in the field of zoology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock or fisheries; testing the functionality of machines, research on machines and laboratory apparatus and instruments; design for others of machinery and scientific research equipment, including design for others of the structural parts comprising the foregoing machinery and equipment; providing information and advice on computer system design and use of information technology to process information in the medical field, said information and advice provided via computer; computer software design, computer programming, or maintenance of computer software; providing temporary use of on-line, non-downloadable computer programs for medical image analysis via computers; rental of computers; providing temporary use of on-line, non-downloadable computer programs on data networks for the purpose of gathering, managing and reporting on scientific data, research and analysis

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 10, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 4, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 18, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 18, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 10, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 10, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Aug 25, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 25, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 25, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 5, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 5, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 5, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 24, 2020 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 17, 2020 OPNX
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 6, 2020 GNFN
FINAL REFUSAL E-MAILED
Apr 6, 2020 GNFR
FINAL REFUSAL WRITTEN
Apr 6, 2020 CNFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 1, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 1, 2020 OPNR
EXAMINER'S AMENDMENT ENTERED
Feb 24, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 24, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 24, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 24, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 6, 2020 GNFN
FINAL REFUSAL E-MAILED
Feb 6, 2020 GNFR
FINAL REFUSAL WRITTEN
Feb 6, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2020 CRFA
ASSIGNED TO LIE
Jan 4, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2019 CRFA
ASSIGNED TO LIE
Jun 5, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 31, 2019 TROA
REFUSAL PROCESSED BY IB
Dec 21, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 4, 2018 RFCS
REFUSAL PROCESSED BY MPU
Dec 4, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 16, 2018 RFCR
NON-FINAL ACTION WRITTEN
Nov 15, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 13, 2018 MAFR
ASSIGNED TO EXAMINER
Nov 7, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 1, 2018 REPR